BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34003571)

  • 61. Reply: Insights and challenges in the management of oral lesions in patients with COVID-19.
    Brandão TB; Gueiros LA; Melo TS; Prado-Ribeiro AC; Prado GVB; Santos-Silva AR; Migliorati CA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jul; 132(1):120-121. PubMed ID: 34022767
    [No Abstract]   [Full Text] [Related]  

  • 62. Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection.
    Khamis F; Memish Z; Bahrani MA; Dowaiki SA; Pandak N; Bolushi ZA; Salmi IA; Al-Zakwani I
    J Infect Public Health; 2021 Jun; 14(6):759-765. PubMed ID: 34022734
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development of leading first-generation vaccines against SARS-CoV-2.
    Perera PY; Perera LP
    Microbes Infect; 2021; 23(8):104841. PubMed ID: 34022375
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection.
    Vicenti I; Gatti F; Scaggiante R; Boccuto A; Zago D; Basso M; Dragoni F; Zazzi M; Parisi SG
    Int J Infect Dis; 2021 Jul; 108():176-178. PubMed ID: 34022329
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19.
    Lowery SA; Sariol A; Perlman S
    Cell Host Microbe; 2021 Jul; 29(7):1052-1062. PubMed ID: 34022154
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preventing SARS-CoV-2 transmission in the emergency department by implementing a separate pathway for patients with respiratory conditions.
    Alqahtani F; Alanazi M; Alassaf W; Aleanizy FS; Aljahany M; Joseph M; AlRaye M
    J Complement Integr Med; 2022 Jun; 19(2):383-388. PubMed ID: 34022123
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 'It's a minefield': COVID vaccine safety poses unique communication challenge.
    Remmel A
    Nature; 2021 May; 593(7860):488-489. PubMed ID: 34021288
    [No Abstract]   [Full Text] [Related]  

  • 68. Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study.
    Ikeda S; Misumi T; Izumi S; Sakamoto K; Nishimura N; Ro S; Fukunaga K; Okamori S; Tachikawa N; Miyata N; Shinkai M; Shinoda M; Miyazaki Y; Iijima Y; Izumo T; Inomata M; Okamoto M; Yamaguchi T; Iwabuchi K; Masuda M; Takoi H; Oyamada Y; Fujitani S; Mineshita M; Ishii H; Nakagawa A; Yamaguchi N; Hibino M; Tsushima K; Nagai T; Ishikawa S; Ishikawa N; Kondoh Y; Yamazaki Y; Gocho K; Nishizawa T; Tsuzuku A; Yagi K; Shindo Y; Takeda Y; Yamanaka T; Ogura T
    Sci Rep; 2021 May; 11(1):10727. PubMed ID: 34021229
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.
    Le Vu S; Jones G; Anna F; Rose T; Richard JB; Bernard-Stoecklin S; Goyard S; Demeret C; Helynck O; Escriou N; Gransagne M; Petres S; Robin C; Monnet V; Perrin de Facci L; Ungeheuer MN; Léon L; Guillois Y; Filleul L; Charneau P; Lévy-Bruhl D; van der Werf S; Noel H
    Nat Commun; 2021 May; 12(1):3025. PubMed ID: 34021152
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.
    Zhang Y; Chen Y; Li Y; Huang F; Luo B; Yuan Y; Xia B; Ma X; Yang T; Yu F; Liu J; Liu B; Song Z; Chen J; Yan S; Wu L; Pan T; Zhang X; Li R; Huang W; He X; Xiao F; Zhang J; Zhang H
    Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34021074
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Air pollution impacts of COVID-19-related containment measures.
    Chossière GP; Xu H; Dixit Y; Isaacs S; Eastham SD; Allroggen F; Speth RL; Barrett SRH
    Sci Adv; 2021 May; 7(21):. PubMed ID: 34020946
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recent Antiviral Treatment and Vaccination Strategies Against SARS-CoV-2.
    Bormann M; van de Sand L; Witzke O; Krawczyk A
    Klin Monbl Augenheilkd; 2021 May; 238(5):569-578. PubMed ID: 34020485
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study.
    Ageno W; De Candia E; Iacoviello L; Di Castelnuovo A;
    Thromb Res; 2021 Jul; 203():138-141. PubMed ID: 34020162
    [No Abstract]   [Full Text] [Related]  

  • 74. Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study.
    Frija-Masson J; Debray MP; Boussouar S; Khalil A; Bancal C; Motiejunaite J; Galarza-Jimenez MA; Benzaquen H; Penaud D; Laveneziana P; Malrin R; Redheuil A; Donciu V; Lucidarme O; Taillé C; Guerder A; Arnoult F; Vidal-Petiot E; Flamant M; Similowski T; Morelot-Panzini C; Faure M; Lescure FX; Straus C; d'Ortho MP; Gonzalez-Bermejo J
    Respir Med; 2021 Aug; 184():106435. PubMed ID: 34020126
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.
    Dal-Ré R; Bekker LG; Gluud C; Holm S; Jha V; Poland GA; Rosendaal FR; Schwarzer-Daum B; Sevene E; Tinto H; Voo TC; Sreeharan N
    Lancet Infect Dis; 2021 Nov; 21(11):e342-e347. PubMed ID: 34019801
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Remote management of dental problems in children during and post the COVID-19 pandemic outbreak: A teledentistry approach.
    Nuvvula S; Mallineni SK
    Dent Med Probl; 2021; 58(2):237-241. PubMed ID: 34019745
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Rapid Assessment of the Impact of COVID-19 on Asian Americans: Cross-sectional Survey Study.
    Quach T; Ðoàn LN; Liou J; Ponce NA
    JMIR Public Health Surveill; 2021 Jun; 7(6):e23976. PubMed ID: 34019478
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mounting evidence for immunizing previously infected subjects with a single dose of SARS-CoV-2 vaccine.
    Marc GP; Alvarez-Paggi D; Polack FP
    J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 34018969
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant.
    Hodgson D; Flasche S; Jit M; Kucharski AJ; ;
    Euro Surveill; 2021 May; 26(20):. PubMed ID: 34018481
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CD8
    Bange EM; Han NA; Wileyto P; Kim JY; Gouma S; Robinson J; Greenplate AR; Hwee MA; Porterfield F; Owoyemi O; Naik K; Zheng C; Galantino M; Weisman AR; Ittner CAG; Kugler EM; Baxter AE; Oniyide O; Agyekum RS; Dunn TG; Jones TK; Giannini HM; Weirick ME; McAllister CM; Babady NE; Kumar A; Widman AJ; DeWolf S; Boutemine SR; Roberts C; Budzik KR; Tollett S; Wright C; Perloff T; Sun L; Mathew D; Giles JR; Oldridge DA; Wu JE; Alanio C; Adamski S; Garfall AL; Vella LA; Kerr SJ; Cohen JV; Oyer RA; Massa R; Maillard IP; Maxwell KN; Reilly JP; Maslak PG; Vonderheide RH; Wolchok JD; Hensley SE; Wherry EJ; Meyer NJ; DeMichele AM; Vardhana SA; Mamtani R; Huang AC
    Nat Med; 2021 Jul; 27(7):1280-1289. PubMed ID: 34017137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.